sirolimus eluting stent

Related by string. sirolimus eluting stents * Sirolimus : CYPHER R Sirolimus eluting . CYPHER ® Sirolimus eluting . Sirolimus eluting Coronary Stent . CYPHER R Sirolimus Eluting / eluted . Eluting : Resolute drug eluting . drug eluting stent implantation . paclitaxel eluting coronary stent / stenting . Stent . Stents : stents inserted . drug coated stents . Endeavor stent * *

Related by context. All words. (Click for frequent words.) 75 sirolimus eluting 74 sirolimus eluting stents 74 everolimus eluting stent 74 TAXUS Express Stent 72 TAXUS Stent 72 Taxus Stent 71 XIENCE V PROMUS Stent 71 paclitaxel eluting stent 71 zotarolimus eluting stent 70 mm Stent 70 Cypher Stent 69 paclitaxel eluting stents 69 TAXUS stent 69 TAXUS Liberte Stent 69 NEVO ™ 69 Sirolimus eluting Coronary Stent 69 eluting stent 69 XIENCE V stent 69 sirolimus stent 68 tirofiban 68 active comparator 68 CYPHER Stent 68 Coronary Stent 68 zotarolimus 68 binary restenosis 68 diameter stenosis 68 NEVO 68 chlorambucil 68 primary patency 68 target lesion revascularization 67 CYPHER ® Stent 67 paclitaxel eluting 67 segment binary restenosis 67 Doxil ® 67 TAXUS ® 66 carboplatin paclitaxel 66 eptifibatide 66 everolimus eluting stents 66 liposomal doxorubicin 66 unfractionated heparin UFH 66 iodixanol 66 carotid artery stenting CAS 66 definite stent thrombosis 66 unfractionated heparin 66 pegylated liposomal doxorubicin 66 stent DES 66 noninferior 66 comparator arm 66 CYPHER R Sirolimus eluting 66 multicentre randomized 66 TAXUS Liberte Long 66 NEVO TM 66 PROMUS 66 stent BMS 66 FOLFOX4 66 TAXUS 65 idraparinux 65 Flu Cy 65 transfemoral 65 ARB telmisartan 65 TAXUS Element Stent 65 CANCIDAS 65 Nitinol Stent 65 irbesartan 65 CYPHER 65 ribavirin RBV 65 5-FU/LV 65 doxorubicin docetaxel 65 CYPHER ® 65 bivalirudin 65 placebo dexamethasone 65 Sirolimus eluting 65 thrombus aspiration 65 peginterferon alfa 2b 65 melphalan prednisone 65 Stent System 65 plus GP IIb 65 trabeculectomy 65 LEXIVA r 65 DAPT 65 Sirolimus Eluting Coronary Stent 65 eplerenone 65 carotid endarterectomy CEA 65 oral diclofenac 65 nonrandomized 65 TAXUS Express Atom Stent 64 uncoated stent 64 prospective multicenter randomized 64 plus gemcitabine 64 mg QD 64 carotid stenting 64 TAXUS Express 64 micafungin 64 mycophenolate mofetil 64 desvenlafaxine succinate 64 TAXUS Express2 64 CYPHER R Stent 64 pegylated interferon alfa 2b 64 PROMUS Element 64 abacavir lamivudine 64 nondiabetic patients 64 CIMZIA TM certolizumab pegol 64 stent implantation 64 peginterferon alfa 2a 64 TAXUS TM 64 thromboembolic events 64 concurrent chemoradiation 64 #mg BID [001] 64 timolol 64 drug eluting stent 64 mcg QD 64 Randomized Evaluation 64 lopinavir r arm 64 aspirin clopidogrel 64 enoxaparin 64 TM Drug Eluting 64 TAXUS Liberté 64 sirolimus 64 FOLFOX 64 stent restenosis 64 sorafenib Nexavar 64 drug eluting stent DES 64 oral allopurinol 64 PROMUS ® 64 mcg albinterferon alfa 2b 64 fluticasone salmeterol 64 tipranavir r 64 FOLFOX6 64 rosuvastatin #mg 64 ximelagatran 64 plus dexamethasone 64 TACE 64 IIIa inhibitor 63 oxycodone IR 63 Engerix B 63 ReoPro 63 salmeterol fluticasone 63 Atom Stent 63 Prospective Randomized Trial 63 endarterectomy 63 coronary stenting 63 metastatic renal cell carcinoma 63 TAXUS Liberte 63 noninferiority 63 GP IIb IIIa inhibitors 63 drug zotarolimus 63 certolizumab 63 ticagrelor 63 Coronary Stent System 63 multicenter randomized placebo controlled 63 Pegasys ® 63 Cordis Cypher 63 ischemia driven 63 renal artery stenting 63 caspofungin 63 tapentadol ER 63 ibandronate 63 HBeAg negative patients 63 Everolimus Eluting Coronary Stent 63 FOLFIRI 63 revascularizations 63 daunorubicin 63 prospective randomized controlled 63 dacarbazine 63 Patency 63 platinum chromium alloy 63 bivalirudin monotherapy 63 Bivalirudin 63 adalimumab 63 Peginterferon 63 Endeavor drug eluting 63 amoxicillin clavulanate 63 teriflunomide 63 restenosis 63 dabigatran etexilate 63 morphometric vertebral fractures 63 Fludara 63 lispro 63 glimepiride 63 neointimal hyperplasia 63 CsA 63 oxycodone CR 63 EURIDIS 63 ePTFE graft 63 5FU 63 mRCC 63 methotrexate monotherapy 63 lumbar spine BMD 63 gemcitabine Gemzar 63 rFVIIa 63 TAXUS V 62 fluorouracil 62 PROMUS Element Stent 62 mcg BID 62 Navelbine 62 Hycamtin ® 62 pegylated interferon alfa 62 tenecteplase 62 Pegylated Liposomal Doxorubicin 62 LPV r 62 FOLPI 62 TAXUS R 62 olmesartan 62 CYPHER ® Sirolimus eluting 62 ezetimibe simvastatin 62 fondaparinux 62 Peg IFN 62 Hazard Ratio 62 atorvastatin #mg 62 XIENCE V Everolimus Eluting 62 interferon alfa 2b 62 superficial femoral 62 KRAS mutations occur 62 Pred Forte 62 nadolol 62 ritonavir boosted atazanavir 62 MitraClip 62 multicenter randomized controlled 62 pimecrolimus 62 VELCADE melphalan 62 nonresponders 62 lanthanum carbonate 62 acute coronary syndromes ACS 62 achieved statistical significance 62 Sirolimus 62 randomized multicenter 62 OPCAB 62 clodronate 62 saphenous vein grafts 62 TAXUS Element Paclitaxel Eluting 62 LMWH 62 Endeavor stent 62 cobalt chromium 62 ABVD 62 abciximab 62 TAXUS Element 62 tamsulosin 62 interferon alfa 2a 62 splenectomized 62 Endarterectomy 62 thalidomide Thalomid 62 oral rivaroxaban 62 fluvastatin 62 standard chemotherapy regimen 62 DOXIL 62 composite endpoint 62 CR nPR 62 ipsilateral stroke 62 TMC# r 62 vinorelbine 62 APTIVUS r 62 SPIRIT FIRST 62 radical nephrectomy 62 decitabine 62 NAVISTAR R 62 CIMZIA ™ 62 colorectal liver metastases 62 insulin detemir 62 angiographic outcomes 62 PegIntron 62 octreotide LAR 62 antiarrhythmic drug 62 mg qd 62 NMIBC 62 achieved ACR# 62 multivessel disease 62 PROMUS TM 62 tacrolimus ointment 62 EBRT 62 defibrillator CRT D 62 voriconazole 62 MoxDuo TM IR 62 Eluting Coronary Stent System 62 carotid artery stenting 62 NSTE ACS 62 ULORIC 62 stenting 62 MACCE 62 somatostatin analog 62 metastatic malignant 62 cilostazol 62 degarelix 62 everolimus eluting 62 SVR# 62 EDEMA3 62 Pemetrexed 62 Combo Stent 61 tigecycline 61 CorVue ™ 61 CIMZIA TM 61 chemoradiation therapy 61 Vfend 61 neointimal 61 lopinavir r 61 ™ Everolimus Eluting 61 Amrubicin 61 mg clopidogrel 61 Angiographic 61 RE LY 61 evaluating tivozanib 61 esomeprazole 61 p = NS 61 temsirolimus 61 idarubicin 61 drug eluting coronary stent 61 #.#mg/dL 61 V Everolimus Eluting Coronary 61 crizotinib PF # 61 #mg QD [002] 61 Acute Ischemic Stroke 61 percutaneous intervention 61 tocilizumab 61 DU #b 61 bypass graft CABG surgery 61 nab paclitaxel 61 TAXUS Liberte stent 61 Durezol 61 sunitinib malate 61 PROMUS Element Everolimus Eluting 61 drug eluting coronary stents 61 radial artery grafts 61 platelet inhibitor 61 tiotropium 61 Taxus Liberte 61 clopidogrel Plavix 61 epirubicin cyclophosphamide 61 BRIM2 61 antiplatelet agent 61 trials RCTs 61 rivaroxaban 61 Kaplan Meier analysis 61 platinum chromium PROMUS 61 NPH insulin 61 estramustine 61 ARCOXIA 61 recurrent GBM 61 low dose dexamethasone 61 Heparin Bioactive Surface 61 placebo controlled clinical 61 Long Lesion 61 hemodynamically significant 61 TAXUS Liberté stent 61 dalteparin 61 HCV RESPOND 2 61 stents BMS 61 receiving VICTRELIS 61 de novo lesions 61 IFN alfa 61 capecitabine Xeloda 61 ABSORB trial 61 sipuleucel T 61 Platinol 61 dual antiplatelet therapy 61 TPV r 61 imipenem 61 Resolute drug eluting 61 chemoradiotherapy 61 oral Hycamtin 61 CRESTOR #mg 61 Stenting Trial CREST 61 prospective randomized 61 Stenting 61 icatibant 61 Free Survival PFS 61 ritonavir boosted 61 MitraClip device 61 mg TID 61 Dabigatran 61 5 Fluorouracil 61 Target Lesion Revascularization TLR 61 XELOX 61 Bare Metal Stent 61 plus prednisone 61 galiximab 61 mitomycin 61 nicardipine 61 relapsed refractory multiple myeloma 61 xanthine oxidase inhibitor 61 plus methotrexate 61 ATACAND 61 receiving prophylactic anticoagulation 61 abluminal 61 CHOP chemotherapy 61 tenofovir emtricitabine 61 stent binary restenosis 61 Taxus Liberté 61 infrapopliteal 61 MabCampath 61 pamidronate 61 TEAEs 61 recurrent glioblastoma multiforme 61 plus ribavirin 61 ALVESCO 61 ROCKET AF 61 MULTI LINK VISION 61 neoadjuvant 61 goserelin 61 ceftazidime 61 tolvaptan 61 gemcitabine cisplatin 61 GORE TAG Device 61 intravenous cyclophosphamide 61 relapsed MM 61 Stenting Trial 61 Element Stent 61 ketorolac 61 dose atorvastatin 61 placebo p = 61 oblimersen 61 PRECiSE 61 GAMMAGARD 61 Cypher Sirolimus 60 ACTEMRA TM 60 adjunctive placebo 60 Pegasys peginterferon alfa 2a 60 cisplatin vinorelbine 60 levosimendan 60 pharmacologically active isomer 60 multicenter placebo controlled 60 β blockers 60 R Paclitaxel Eluting 60 cinacalcet 60 XIENCE V demonstrated 60 Thrombolysis 60 median PFS 60 aspirin heparin 60 Events MACE 60 non inferiority 60 tapentadol IR 60 docetaxel Taxotere ® 60 glatiramer acetate 60 paricalcitol 60 bioprosthesis 60 rt PA 60 Vascugel ® 60 gadobutrol 60 alpha blocker 60 infliximab monotherapy 60 Genous stent 60 peginterferon alfa 2a Pegasys 60 trabectedin 60 ertapenem 60 Lenalidomide 60 oral levofloxacin 60 Drug eluting stent 60 brand ciclesonide HFA 60 ARIXTRA 60 amphotericin B 60 IIIa inhibitors 60 CORDAPTIVE 60 Emboli Capture Guidewire 60 Biolimus A9 60 TAXUS IV 60 GP IIb IIIa inhibitor 60 transapical 60 STRIDE PD 60 bosentan 60 restenotic lesions 60 reintervention 60 microbiological eradication 60 primary percutaneous coronary 60 Copegus ribavirin 60 Elitek 60 gemcitabine carboplatin 60 benazepril 60 atazanavir ritonavir 60 antithrombotics 60 rhBMP 2 60 ribavirin Copegus ® 60 dexamethasone Decadron 60 unstable angina UA 60 Taxotere ® 60 infusional 5-FU/LV 60 stage IIIb IV 60 arterial thromboembolic events 60 liposomal formulation 60 q8h 60 MIRAPEX 60 5 FU leucovorin 60 Drug Eluting Stents 60 elective PCI 60 Edwards SAPIEN XT 60 Fludarabine 60 Xience V 60 prospectively randomized 60 tolterodine ER 60 reinfarction 60 saline placebo 60 virologic response 60 Embolic Protection System 60 APTIVUS 60 workhorse lesions 60 CYPHER R 60 intra aortic balloon 60 cediranib 60 sorafenib Nexavar ® 60 OZURDEX ® 60 bezafibrate 60 partial remissions 60 Drug Eluting Stent 60 TAXUS ATLAS 60 Betaferon R 60 Rivaroxaban 60 dose dexamethasone 60 administered subcutaneously 60 recanalization 60 Aptivus ® 60 4mg/kg 60 alpha 2b 60 vorinostat 60 metastatic HRPC 60 bendamustine 60 TAXUS Express2 Paclitaxel Eluting 60 dose cytarabine 60 mg kg dose 60 clopidogrel Plavix ® 60 SYNTAX trial 60 periprocedural 60 Vaprisol 60 transarterial 60 FOLFOX4 alone 60 ug dose 60 bioabsorbable polymer 60 Bare Metal Stents 60 pertuzumab 60 #Gy 60 biologic DMARD 60 valsartan 60 subcutaneously administered 60 P = .# 60 prospective multicenter 60 TURP 60 pulsatile flow 60 intravesical therapy 60 mg ustekinumab 60 RE LY ® 60 Anti Bacterial Envelope 60 etanercept 60 ZoMaxx 60 zolmitriptan 60 Eluting Stent 60 multicenter randomized 60 HBeAg seroconversion 60 SYNERGY Stent 60 resectable 60 formoterol fumarate 60 Endeavor Resolute 60 TAXUS VI 60 Tryton Side Branch 60 infrarenal 60 liposome injection 60 pomalidomide 60 RAPAFLO R 60 Fulvestrant 60 rizatriptan 60 strontium ranelate 60 bevacizumab Avastin R 60 IFN α 60 Platinol ® cisplatin 60 Enoxaparin 60 plus glycoprotein IIb 60 balloon kyphoplasty 60 pegylated interferon alpha 60 stent thromboses 60 #mg dose [003] 60 Endoprosthesis 60 Dasatinib 60 chemotherapy gemcitabine 60 SPIRIT III 60 azilsartan medoxomil 60 otamixaban 60 endovascular repair 60 symptomatic VTE 60 cangrelor 60 Xience Prime 60 regorafenib 60 Restenosis 60 stable angina pectoris 60 ABC/3TC 60 efavirenz EFV 60 relapsing multiple sclerosis 59 Resolute DES 59 bolus dose 59 stented 59 Pertuzumab 59 transthoracic 59 angiographic restenosis 59 PEGINTRON TM 59 NATRECOR R 59 NAVISTAR ® THERMOCOOL ® 59 colorectal adenoma 59 PEG IFN 59 TELCYTA 59 IV bolus 59 levofloxacin 59 daily Infergen 59 HMG CoA reductase inhibitor 59 metastatic GIST 59 Camptosar ® 59 Pioglitazone 59 VESTAsync 59 ASTEROID 59 temsirolimus Torisel 59 myocardial reperfusion 59 methotrexate MTX 59 LV dysfunction 59 fluticasone 59 #mg/day [001] 59 deep venous thromboses 59 nodular partial response 59 COPEGUS 59 SYNTAX 59 LVEF 59 preoperative chemotherapy 59 XIENCE TM 59 reteplase 59 beta estradiol 59 mitoxantrone 59 discontinuations due 59 TAXUS p value 59 docetaxel Taxotere 59 vandetanib 59 docetaxel prednisone 59 NOXAFIL 59 ACR# response 59 percutaneous transluminal coronary angioplasty 59 metaglidasen 59 paclitaxel stent 59 angiotensin converting enzyme inhibitor 59 doxorubicin cyclophosphamide 59 carotid artery stent 59 Tarceva TM 59 coronary drug eluting 59 lymphadenectomy 59 double blinded randomized 59 mapatumumab 59 prior relapsers 59 eluting stents 59 HeartMate XVE 59 Medoxomil 59 randomized #:#:# 59 erlotinib Tarceva ® 59 locoregional recurrence 59 Taxus Element 59 #mg doses [002] 59 atrasentan 59 adenoma recurrence 59 events MACE 59 Folfox 59 Carotid Revascularization Endarterectomy vs. 59 latanoprost 59 TAVI 59 doripenem 59 Acute Myocardial Infarction 59 beclomethasone dipropionate 59 triamcinolone 59 CYPHER SELECT TM 59 PROMUS R 59 TAVR 59 invasive candidiasis 59 CYPHER R Sirolimus Eluting 59 graft patency 59 herpetic keratitis 59 nadroparin 59 lamivudine monotherapy 59 pioglitazone 59 fallopian tube cancers 59 olmesartan medoxomil 59 statistically significant p = 59 budesonide formoterol 59 peginterferon alfa 2a #KD 59 PASI scores 59 plus COPEGUS 59 ara C 59 GORE EXCLUDER AAA Endoprosthesis 59 metastatic neuroendocrine tumors 59 TORISEL 59 TM Everolimus Eluting 59 VFEND 59 vincristine doxorubicin 59 Myocardial Infarction Study 59 budesonide 59 PREZISTA r 59 target vessel revascularization 59 patients undergoing CABG 59 cardiac resynchronisation therapy 59 alpha 2a 59 prucalopride 59 telmisartan 59 adalimumab Humira 59 Stent thrombosis 59 randomized Phase III 59 GOUT 59 cabazitaxel 59 Prograf ® 59 bypass grafting 59 mid urethral sling 59 transurethral 59 peginterferon 59 Traficet EN 59 infusional 59 Study Evaluating 59 #mg BID [003] 59 mg BID 59 Alkeran 59 carotid stents 59 8mg/kg 59 boosted protease inhibitor 59 prospective randomized multicenter 59 Irinotecan 59 Randomized Clinical Trial 59 retropubic 59 Tacrolimus 59 Mg Usa 59 Pharmacokinetics PK 59 systemic embolism 59 enalapril 59 dacarbazine chemotherapy 59 simvastatin ezetimibe 59 docetaxel chemotherapy 59 receptor blocker 59 SCH # 59 adjuvant radiotherapy 59 posaconazole 59 mitomycin C 59 Pivotal Clinical Trial 59 pegylated interferons 59 saphenous vein graft 59 GORE VIABAHN Endoprosthesis 59 postintervention 59 Percutaneous Coronary Intervention 59 zonisamide SR 59 Express2 TM paclitaxel eluting 59 Platinum Chromium Coronary Stent 59 deferoxamine 59 transurethral resection 59 postoperative chemotherapy 59 lamotrigine 59 lipid lowering agents 59 gefitinib Iressa 59 azacytidine 59 catheter occlusion 59 L PPDS 59 BENICAR 59 FOLFIRI alone 59 HepaSphere 59 CK # administered 59 imiquimod cream 59 KRAS wild 59 MiStent DES 59 palonosetron 59 candesartan 59 tumor xenograft models 59 liposomal amphotericin B 59 angiotensin converting enzyme inhibitors 59 infliximab 59 undetectable HBV DNA 59 ancrod 59 Dyloject TM 59 primary hypercholesterolemia 59 thromboembolic 59 intravitreal injection 59 chemoradiation 59 leukemia AML 59 ustekinumab 59 pegylated interferon peg IFN 59 evaluating REVLIMID 59 TRITON TIMI 59 Cilostazol 59 etanercept Enbrel 59 placebo p 59 repeat revascularization 59 alicaforsen enema 59 unstable angina pectoris 59 APTIVUS R 59 risperidone Risperdal 59 Protelos 59 IFN beta 59 Platinol ® 59 Paclitaxel eluting 59 ribavirin USP 59 quetiapine risperidone 58 undergoing coronary artery 58 CCyR 58 clopidogrel 58 pneumonectomy 58 Trastuzumab 58 Vascular Wrap 58 advanced adenomas 58 locoregional disease 58 CLARITY study 58 Perforomist Inhalation Solution 58 paclitaxel Taxol 58 ACTEMRA 58 reslizumab 58 stage IIIB 58 alfa 2a 58 Navelbine ® 58 ischemic cardiomyopathy 58 titrated glipizide 58 patients evaluable 58 recombinant tissue plasminogen 58 non squamous NSCLC 58 multicenter Phase III 58 iniparib 58 sustained virological response 58 Pegylated Interferon 58 INTEGRILIN ® 58 eluting coronary stent 58 Median PFS 58 vicriviroc 58 evaluable subjects 58 BENICAR HCT 58 functional mitral regurgitation 58 Telmisartan 58 multicenter multinational 58 comparator PI r 58 recurrent VTE 58 PressureWire 58 TEMODAL 58 intracoronary 58 pulmonary artery banding 58 assessing T DM1 58 pimecrolimus cream 58 fosamprenavir 58 serum phosphorus 58 ramipril 58 Etoposide 58 VAPRISOL 58 bupivacaine 58 GPIIb IIIa inhibitors 58 azacitidine 58 cidofovir 58 follicular lymphoma FL 58 Degarelix 58 metastatic malignant melanoma 58 mTOR inhibitor 58 Gliadel Wafer 58 EverFlex 58 carotid stent 58 efficacy endpoint 58 Peginterferon Alfa 2a 58 PFO closure 58 azathioprine 58 aldosterone antagonist 58 liver resection 58 paroxysmal AF 58 pemetrexed 58 NXL# 58 Catheter ablation 58 intravesical 58 Major Adverse Cardiac 58 Betaferon ® 58 PERSEUS clinical program 58 scleral buckling 58 Paraplatin ® 58 FUSILEV enhances 58 trandolapril 58 Pivotal Trial 58 XGEVA 58 Thal Dex 58 angiographic follow 58 drug eluting stents 58 bi ventricular pacing 58 ENDEAVOR IV 58 patients undergoing percutaneous 58 nonoperative 58 Carotid 58 % CI #.#-#.# [003] 58 Self Expanding Stent 58 intravitreal injections 58 neoadjuvant treatment 58 CAELYX 58 ritonavir boosted lopinavir 58 miconazole Lauriad ® 58 NATRECOR ® 58 Oral Fingolimod 58 analgesic efficacy 58 EOquin TM 58 candesartan cilexetil 58 placebo 58 dasatinib Sprycel ® 58 dutasteride 58 REYATAZ R 58 oral anticoagulants 58 PREZISTA ritonavir 58 ALGRX 58 nilotinib 58 febrile neutropenia 58 multicentre randomized double 58 virologic failure 58 Capecitabine 58 intra arterial 58 steroid dexamethasone 58 Retisert TM 58 venlafaxine XR 58 Alocrest 58 achieved CCyR 58 HydroCoil 58 fibrinolysis 58 TMC# C# 58 non splenectomized 58 antegrade 58 flutamide 58 mg BID dose 58 abacavir Ziagen 58 ARCALYST ® 58 parecoxib 58 achieved PASI 58 neoadjuvant therapy 58 Evicel 58 levetiracetam 58 INTEGRILIN R 58 Interferon alfa 58 stenoses 58 basiliximab 58 FOSRENOL ® 58 Express2 TM 58 PICSO ® 58 cetuximab Erbitux ® 58 bivalirudin alone 58 TO AVOID PREGNANCY WHILE 58 aldosterone antagonists 58 thinner struts 58 metastatic CRC 58 active moiety 58 ostial 58 subanalysis 58 anti arrhythmic drug 58 atherothrombotic events 58 recurrent NSCLC 58 FluCAM arm 58 bupropion SR 58 pegfilgrastim 58 IOP lowering 58 rosuvastatin 58 symptomatic paroxysmal AF 58 milrinone 58 3TC lamivudine Epivir 58 evaluable 58 Q2W 58 #beta estradiol 58 MGd 58 intravascular ultrasound IVUS 58 PSA nadir 58 thrombolytics 58 angiotensin receptor blocker ARB 58 FASLODEX 58 neoadjuvant chemotherapy 58 Carvedilol 58 free survival PFS 58 multicenter clinical 58 topotecan 58 transcatheter 58 Aflibercept 58 randomized #:# 58 Sym# 58 mCi kg 58 coronary stenosis 58 apremilast 58 debulking surgery 58 intravenous dosing 58 bioabsorbable stent 58 HoLEP 58 sustained virologic response 58 stents coated 58 vertebral fracture 58 secondary efficacy endpoints 58 COMBIVIR 58 glycoprotein IIb IIIa inhibitor 58 rebleeding 58 AZT zidovudine Retrovir 58 telaprevir dosed 58 Burch colposuspension 58 direct thrombin inhibitors 58 oxybutynin 58 cariprazine 58 alteplase 58 drotrecogin alfa activated 58 doxorubicin 58 percutaneous vertebroplasty 58 HBeAg positive patients 58 bovine thrombin 58 Randomised 58 Adhibit 58 sunitinib 58 paclitaxel Taxol ® 58 stent 58 COR Analyzer 58 endothelialization 58 PegIFN 58 Taxus Liberte stent 58 esomeprazole Nexium 58 ranolazine 58 typical antipsychotics 58 pharmacokinetic PK 58 ziprasidone Geodon 58 antiarrhythmic drugs 58 dexmedetomidine

Back to home page